It was an honor to contribute to the NIH Clinical Center Grand Rounds this week—a straightforward presentation of a fascinating case, followed by the brilliant Drs. Kreitman and Pastan discussing the anti-CD22 immunotoxin Moxetumomab.
You can also view the talk on the NIH videocast page. Those fortunate few who have the time could spend days browsing through old lectures. Better use of resources that watching a TED talk, I'd say.